🏅 FDA Orphan Designation
Hexalen
Altretamine
Manufacturer: Medimmune Oncology, Inc.
Indicated for:📚 Clear cell adenocarcinoma of the ovary
Indications & Usage
Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination.
💙 Support Programs
View all →Hexalen
Medimmune Oncology, Inc.
Hexalen
Medimmune Oncology, Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.